Stay updated with breaking news from Optimind Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Psychedelics therapy provider Optimind Pharma Corp. entered into an acquisition agreement with Wolf Acquisitions 1.0 Corp., an arm's length private British Columbia corporation with investments in the psychedelics industry and one of its wholly-owned subsidiaries.
TORONTO, Oct. 12, 2023 -- Optimind Pharma Corp. is pleased to announce that it has entered into an acquisition agreement dated October 12, 2023 with Wolf Acquisitions 1.0 Corp. , an arm's length...
Optimind looks to accelerate the adoption of the MindSetting TRIP Protocol for ketamine-assisted therapy and other psychedelic enhanced psychotherapy modalities. Toronto, Ontario--(Newsfile Corp. - September
Toronto, Ontario--(Newsfile Corp. - June 16, 2022) - Loon Energy Corporation (TSXV: LNE) (the "Company") is pleased to announce that it has applied for listing of its common shares on the Canadian Securities
Toronto, Ontario--(Newsfile Corp. - April 4, 2022) - Loon Energy Corporation (TSXV: LNE) (the "Company" or "Loon") and Optimind Pharma Inc. ("Optimind") have entered into a second amending agreement to